News

24.02.2010

Celonic presenting in Zurich and Barcelona
After the CEO Forum in Zurich in February, Andreas Herrmann will present Celonic on the occasion of BIO-Europe Spring in Barcelona in March. The core content of his presentation will be the status of Celonic's biopharmaceutical pipeline. Currently, Celonic is developing an enzyme against cancer and two proteins against inflammatory diseases. While one antibody promises to be more efficient than competitive products that are available on the market, a fusion protein can address unmet needs where other therapeutics fail.

Andreas Herrmann is going to give the presentation on Tuesday, 9 March, at 12 a.m.




> back
Next step in Celonic's analytical portfolio

Juelich receives GMP certificate

Find a job at Celonic

Challenging positions in development, production, downstream processing and quality control